Pd26-03 early results of the new rigicon infla10® three-piece inflatable penile prosthesis in 535 patients with erectile dysfunction

You have accessJournal of UrologyCME1 Apr 2023PD26-03 EARLY RESULTS OF THE NEW RIGICON INFLA10® THREE-PIECE INFLATABLE PENILE PROSTHESIS IN 535 PATIENTS WITH ERECTILE DYSFUNCTION Steven K. Wilson, Mariano Rossello, Pedro Maria, and Lexiaochuan Wen Steven K. WilsonSteven K. Wilson More articles by this author , Mariano RosselloMariano Rossello More articles by this author , Pedro MariaPedro Maria More articles by this author , and Lexiaochuan WenLexiaochuan Wen More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003304.03AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Implantation of a penile prosthesis may be considered in patients who do not respond to more conservative therapies or prefer a definitive therapy. Inflatable Penile Prosthesis implantation has been associated with high patient satisfaction rates. The aim of this study is to investigate the safety outcomes of the new Infla10® Three-Piece Inflatable Penile Prosthesis (Rigicon, New York) in patients with erectile dysfunction. METHODS: 535 patients who underwent Infla10® Three-Piece Inflatable penile prosthesis implantation between 01.06.2019 to 08.04.2022 were included in the study. 103 surgeons from 26 centers participated in the study. All patients were followed up to evaluate the safety of the device. Revision/explantation, and rates of reoperation for infection, mechanical failure, or medical reasons were recorded. SPSS 25.0 (IBM, US) was used for the statistical analysis of the patient demographics and Kaplan Meier survival statistics. RESULTS: The mean follow-up was 24.2 months with a range of 7-36 months. The mean patient age was 56.23 years. The mechanical failure rate was 2.24%, explantation due to patient dissatisfaction was 0.19 %, Peyronie’s failed correction was 0.19%, and component out of place was 0.37%, infection rate was 0.19%. Survival analysis of the device at 12, 24, and 36 months was 96.6%, 97.8%, and 96.8%, respectively, until surgical invention. CONCLUSIONS: Early results suggest that Infla10® Three-Piece Inflatable Penile Prosthesis insertion offers comparable safety outcomes in the treatment of patients diagnosed with erectile dysfunction. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e736 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Steven K. Wilson More articles by this author Mariano Rossello More articles by this author Pedro Maria More articles by this author Lexiaochuan Wen More articles by this author Expand All Advertisement PDF downloadLoading ...